Please login to the form below

Not currently logged in


This page shows the latest evidence news and features for those working in and with pharma, biotech and healthcare.

Roche to buy cancer data firm Flatiron for $1.9bn

Roche to buy cancer data firm Flatiron for $1.9bn

Swiss pharma group Roche has beefed up its big data capabilities with a deal to buy Flatiron Health, which focuses on cancer data and real-world evidence platforms.

Latest news

More from news
Approximately 12 fully matching, plus 1,007 partially matching documents found.

Latest Intelligence

  • A critical juncture for clinical data management A critical juncture for clinical data management

    Real-world data and evidence, electronic clinical outcome assessments, data from smartphones and other mobile devices, social media community data and electronic health/medical records are examples of the new data

  • The Patient Safety Challenge The Patient Safety Challenge

    We now have scientific evidence of causes of medication errors and why they are not always reported.

  • Six degrees of participation Six degrees of participation

    Pharma has the opportunity to progress from tailored insights to real-world, localised evidence, ”says Dennis O’Brien. ... That’s powerful evidence. And it’s right at our fingertips in most therapy areas.

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    science, evidence and the imperative to establish new routes to deal with an ageing world population susceptible to multiple co-morbidities.

  • The valuable brand The valuable brand

    If you need evidence of this, consider how few launches achieve their goals, the frequent rejection of new products by HTAs or the increasing price pressure faced by even successful brands. ... Evolved value. There is ample evidence that approaches to

More from intelligence
Approximately 8 fully matching, plus 224 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Better Insights Come from Better Evidence

    Better Insights Come from Better Evidence. Over the last few years, health has moved towards an outcome-driven and patient-centric ecosystem. ... This era is driving patients, payers and healthcare providers to become super-consumers, with pharmaceutical

  • Rapid career progression at Porterhouse Medical

    She was also the first member of the scientific services team to work with Fabrice Allum in our new research, insight and evidence consultancy, Porterhouse Insights, receiving excellent client feedback.

  • Changing behaviour by design

    While creativity is vital in changing behaviour through design, it is also imperative to ground interventions in robust research evidence and psychological literature.

  • It’s time to ditch the stereotypes

    At Hamell, we have developed a framework for understanding and explaining behaviour based on integrated evidence from across the behavioural sciences.

  • Healthy narratives?

    Whatever the merits of the emerging evidence, it has a mountain to climb when it comes to getting a foothold. ... We are also 'risk averse' - we revert to safe positions (conventional wisdom) and are sceptical of emerging evidence.

More from PMHub
Approximately 4 fully matching, plus 214 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...